Gland Pharma sets up R&D centre near Hyderabad
By Our Corporate Bureau | 28 Nov 2002
Hyderabad: Gland Pharma, a leading manufacturer of injectables has added a new research and development (R&D) pilot plant, with an investment of Rs 7 crore at Dundigal, about 20 km from Hyderabad.
The plant, inaugurated by the German Ambassador to India, Mr Heimo Richter, on Tuesday, would facilitate the R&D activities and manufacture of high-value small-volume products. The company has several products at R&D stage, which will get a boost for conversion into commercial grade.
The R&D plant has been named after McLean, the inventor of Heparin. Gland Pharma has a joint venture with the Vetter Group, Germany, Europe''s leading contract manufacturing company for injectables in pre-filled syringes. It also has an equity partnership from DEG German Investment and Development Company.
.jpg "RBI keeps repo rate unchanged as focus remains on inflation")
.jpg "Indian Oil, Panasonic team up for lithium-ion cell production in India")
